Jinhe Biotechnology CO., LTD. (SHE:002688)
China · Delayed Price · Currency is CNY 6.34
+0.05 (0.79%)
Feb 4, 2026, 3:04 PM CST
SHE:002688 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 125.51 | 100.2 | 86.46 | 75.62 | 93.99 | 117.32 |
Depreciation & Amortization | 193.61 | 193.61 | 179.29 | 155.89 | 132.08 | 119.95 |
Other Amortization | 4.97 | 4.97 | 1.66 | 2.15 | 2.04 | 1.81 |
Loss (Gain) From Sale of Assets | -0.19 | -0.19 | 0.36 | 0.25 | -1.57 | - |
Asset Writedown & Restructuring Costs | 40.87 | 40.87 | 6.56 | 8.2 | 12.33 | 9.81 |
Loss (Gain) From Sale of Investments | 1.27 | 1.27 | -0.15 | 3.94 | - | - |
Provision & Write-off of Bad Debts | 13.99 | 13.99 | 6.31 | 1.53 | 1.88 | 0.28 |
Other Operating Activities | 83.94 | 124.58 | 80.64 | 94.85 | 95 | 88.8 |
Change in Accounts Receivable | -26.29 | -26.29 | -183.89 | -152.49 | -138.64 | -8.22 |
Change in Inventory | 15.15 | 15.15 | 11.51 | -105.57 | -135.58 | -19.85 |
Change in Accounts Payable | 37.08 | 37.08 | -0.52 | 37.42 | 89.13 | -52.04 |
Change in Other Net Operating Assets | 18.24 | 18.24 | 3.84 | - | -0.09 | 10.03 |
Operating Cash Flow | 483.09 | 498.42 | 198.77 | 124.47 | 152.98 | 258.08 |
Operating Cash Flow Growth | 18.39% | 150.76% | 59.69% | -18.63% | -40.72% | -8.54% |
Capital Expenditures | -338.55 | -362.24 | -457.22 | -402.16 | -383.72 | -204.01 |
Sale of Property, Plant & Equipment | 5.95 | 5.68 | 0.01 | 0.06 | 5.38 | 0 |
Cash Acquisitions | - | - | -60.88 | - | -19.24 | -0.3 |
Divestitures | 0.22 | 0.89 | - | 19.5 | - | - |
Investment in Securities | -3 | -15.51 | -20 | -4.2 | -0.1 | -0.1 |
Other Investing Activities | 2.5 | -0.29 | 3.9 | - | - | - |
Investing Cash Flow | -332.89 | -371.46 | -534.19 | -386.8 | -397.99 | -204.41 |
Short-Term Debt Issued | - | - | - | 7 | - | - |
Long-Term Debt Issued | - | 2,049 | 2,033 | 1,601 | 1,240 | 1,249 |
Total Debt Issued | 1,422 | 2,049 | 2,033 | 1,608 | 1,240 | 1,249 |
Short-Term Debt Repaid | - | - | - | -7 | - | - |
Long-Term Debt Repaid | - | -1,866 | -1,440 | -995.53 | -1,574 | -1,103 |
Total Debt Repaid | -1,482 | -1,866 | -1,440 | -1,003 | -1,574 | -1,103 |
Net Debt Issued (Repaid) | -59.31 | 183.08 | 592.77 | 605.86 | -334.09 | 146.54 |
Issuance of Common Stock | - | - | 55.7 | - | 803.48 | - |
Repurchase of Common Stock | -72.05 | -72.05 | - | -131.89 | - | - |
Common Dividends Paid | -152.13 | -160.96 | -148.69 | -40.55 | -104.33 | -222.88 |
Other Financing Activities | -72.72 | 10.05 | -86.72 | -282.99 | 83.65 | 103.94 |
Financing Cash Flow | -356.21 | -39.89 | 413.05 | 150.43 | 448.7 | 27.6 |
Foreign Exchange Rate Adjustments | 0.64 | 3.65 | 9.07 | 21.61 | -2.16 | -7.15 |
Net Cash Flow | -205.37 | 90.72 | 86.7 | -90.28 | 201.54 | 74.13 |
Free Cash Flow | 144.54 | 136.18 | -258.45 | -277.69 | -230.74 | 54.07 |
Free Cash Flow Growth | 63.55% | - | - | - | - | -47.67% |
Free Cash Flow Margin | 5.26% | 5.75% | -11.89% | -13.08% | -11.10% | 2.98% |
Free Cash Flow Per Share | 0.19 | 0.18 | -0.33 | -0.36 | -0.33 | 0.08 |
Cash Income Tax Paid | 33.77 | -13.64 | -14.64 | 5.16 | 13.16 | 31.38 |
Levered Free Cash Flow | 69.08 | 28.67 | -274.92 | -182.28 | -294.44 | -76.67 |
Unlevered Free Cash Flow | 124.62 | 78.88 | -237.41 | -159.53 | -261.73 | -38.95 |
Change in Working Capital | 19.12 | 19.12 | -162.36 | -217.96 | -182.77 | -79.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.